Information
-
Trademark
-
98148105
-
International Classifications
-
Filing Date
August 24, 2023
a year ago
-
Transaction Date
January 18, 2025
26 days ago
-
Status Date
September 17, 2024
4 months ago
-
Published for Opposition Date
July 23, 2024
6 months ago
-
Location Date
September 17, 2024
4 months ago
-
Status Code
688
-
Current Location
INTENT TO USE SECTION
Employee Name
BLAKESLEE, R. AUSTIN
-
Attorney Name
Nancy Wilker
Law Office Assigned Location Code
N50
-
Owners
Mark Drawing Code
4
Mark Identification
HEMERUS
Case File Statements
- GS0051: Chemical reagents for medical purposes, namely, medical solutions used to aid in the anticoagulation, storage or preservation of whole blood and cellular and non-cellular blood products, in particular plasma, platelets, white blood cells, plasma proteins in the nature of immunoglobulins, and red blood cells
- GS0011: Chemical preparations for scientific purposes, namely, chemical solutions used to aid in the anticoagulation, preservation, or storage of whole blood and cellular and non-cellular blood products, in particular plasma, platelets, and red blood cells for scientific and laboratory purposes; chemical preparations for the manufacture of tubing, bags, and filters for collecting or storing whole blood and cellular and non-cellular blood products, in particular plasma, platelets, white blood cells, plasma proteins in the nature of immunoglobulins, and red blood cells
- GS0101: Medical devices, namely, kits for the collection, preservation, or storage of whole blood and cellular and non-cellular blood products, in particular plasma, platelets, white blood cells, and red blood cells, comprised of medical tubing for transfusions, empty blood storage bags, and medical whole blood and cellular and non-cellular blood products, in particular plasma, platelets, plasma proteins in the nature of immunoglobulins, and red blood cells, as well as anticoagulation and chemical storage solutions; filters for blood and blood components for medical use, namely, filters for reducing leukocytes and white blood cells in collected whole blood, and cellular and non-cellular blood products, in particular plasma, platelets, and red blood cells
Case File Event Statements
-
8/28/2023 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
3/22/2024 - 10 months ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
9/24/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
3/19/2024 - 11 months ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/22/2024 - 10 months ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/22/2024 - 10 months ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/18/2024 - 8 months ago
10 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
6/18/2024 - 8 months ago
9 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
6/18/2024 - 8 months ago
8 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
6/18/2024 - 8 months ago
7 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
6/18/2024 - 8 months ago
11 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
7/23/2024 - 6 months ago
14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/3/2024 - 7 months ago
12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
7/23/2024 - 6 months ago
13 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
1/17/2025 - 27 days ago
16 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
9/17/2024 - 4 months ago
15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM